Dollar General Stock Forum

Morning Movers
Gapping Up
$Intel (INTC.US)$ stock surged 12% following the appointment of Lip-Bu Tan, former CEO of Cadence Design Systems, as its new chief executive. Tan replaces interim co-CEOs David Zinsner and MJ Holthaus.
$D-Wave Quantum (QBTS.US)$ stock rose 4.6% in premarket trade as the firm expects revenue to significantly exceed Wall Street consensus as it benefits from the sale of an Advantage annealing quantum computer...

Here are the levels to keep an eye on as DG comes back down. Retest of 74.29 up next.
$Dollar General (DG.US)$  

Little update on the wheel strategy, recently placed a new CSP into $Johnson & Johnson (JNJ.US)$  cause the price was irresistible after their earnings.
Buy the Close yesterday and net premium off: USD 125.00 (approxi. USD 2.00 Fees)
Current Wheel Positions

Green day yesterday and 2 of my options hitted my 50% profit target.
I’ve been eyeing on $Occidental Petroleum (OXY.US)$  since the rebound recently. Market was up strong but it dipped so I opened a CSP.
PNL—since Y2025 : +755 USD
XHS (Redbook) for my journal: Click Here
Buy the Close
Cash Secure Put
Watchlist focus more on Consumer Defensive
1. $Dollar General (DG.US)$
2. $PepsiCo (PEP.US)$
3. $Coca-Cola (KO.US)$

$Dollar General (DG.US)$ Down we go 65.35 is the next stop

$Dollar General (DG.US)$ update tgt achieved of 70 almost near tgt of 70 safe traders may book profits rest full from 81 to 70 book profits full exit now took time sell given on December first week book profits full exit

$Dollar General (DG.US)$ Eyes on this stock 👀 see you in January

$Dollar General (DG.US)$ SELL given at 77 to 79 sl was 81 on closing basis now at below 74 still yet to come holding shorts for more downside from here also took time more then 2 weeks tgt soon now BELOW 72 to 70 also

$Dollar General (DG.US)$ $Zomedica (ZOM.US)$ Zomedica Pharmaceuticals has appointed Scott A. Jordan as Executive Vice President, Finance and Chief Financial Officer, starting January 1, 2025. With over 30 years of experience in the life sciences and diagnostics industries, Jordan’s strategic finance and business development skills are expected to drive Zomedica’s growth in the animal health sector.